Faeth Therapeutics CFO Brian C. Stephenson purchased $36,353 worth of shares at $20.23, marking the largest purchase of his career, which may signal confidence in the company's valuation despite recent volatility.
Price context
The stock has surged 54.3% over the last 5 days and is currently trading 138.42% above its 52-week low of $10.905, though it remains 19.25% below the 52-week high of $32.2.
Catalysts to watch
Insider purchased the largest amount of his career on June 22; next earnings date is unknown.
Risks
The stock is currently trading 19.25% below its 52-week high of $32.2.
AI-generated context from public data. Not investment advice. Verify before trading.